Only 57% of participants reached the highest 2.4mg/2.4mg dose
Elsevier Inc
The companies failed to inform patients about extreme gastrointestinal side effects, including intestinal obstruction, stomach paralysis, severe vomiting, gastroparesis, esophageal tearing, ischemia, among others
its totally fine. Its not fine, and so we have to be willing to recognize that weve been at fault, and we can do better if were only willing to. Fatima Cody Stanford, MD, MPH, MPA, associate professor of medicine and pediatrics, Harvard Medical School
So well, and that's why I love kind of tuning into everything that you're doing and the research that you've spoken about already